Clinical trial Recruiting at 2 sites Interventional Ages 15 to 24

Screening for sexual dysfunction in young cancer survivors

Official title: Stakeholder-Engaged Development and Evaluation of a Screening Approach for Sexual Dysfunction in Adolescent and Young Adult Patients With and Surviving Childhood Cancer

Run by University of Colorado, Denver · NCT05524610 · Data updated 2026-11-12

This study is trying out a new way to check for sexual problems in young cancer survivors aged 15-24 to help doctors better understand and support their needs.

Quick facts

Study typeInterventional
Ages15 Years to 24 Years
SexAll
Enrollment205 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Drugs / interventionsChemotherapy, immunotherapy
Locations2 sites (Aurora, Colorado and 1 other locations)
StatusRecruiting
StartedFebruary 14, 2023
Main results expectedMarch 30, 2027
Study endsJune 30, 2027
Registry record updatedMay 6, 2026
Trial IDNCT05524610 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 15-24 who are currently receiving care or have survived childhood cancer.

Probably not a fit

Patients who are not within the age range of 15-24 or who have not been diagnosed with cancer before the age of 18 may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and implement a standardized screening approach for sexual dysfunction in adolescent and young adult (AYA) patients aged 15-24 who are survivors of childhood cancer. The approach will utilize the Patient Reported Outcome Measurement Information System (PROMIS) for Sexual Function and Satisfaction (SexFS) Brief, integrating feedback from both patients and medical providers. The study will pilot test this screening method across multiple clinics to improve the recognition and management of sexual dysfunction in this population.

Why it matters

Potential benefit: If successful, this study could lead to improved identification and management of sexual dysfunction in young cancer survivors, enhancing their quality of life.

How similar studies have gone: While there have been studies addressing sexual dysfunction in cancer survivors, this specific approach to screening in AYA patients is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1. Provision to sign and date the consent form.
2. Stated willingness to comply with all study procedures and be available for the duration of the study.
3. Be aged 15-24 years old at the time of enrollment
4. Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2)
5. Must have received cancer-directed therapy with at least one of the following:

   * Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy
   * Radiotherapy: any radiotherapy to treat the cancer diagnosis
   * Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery.
6. Cancer must have been diagnosed before the age of 18 years
7. Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

1. Unable to read and speak English
2. Patients who did not receive cancer-directed therapy
3. Insufficient cognitive functioning to complete study measures, as determined by patient's
4. Participation in intervention development
5. Patient is at end of life or on hospice, as determined by primary oncologist
6. Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement
7. Patient is at end of life or on hospice, as determined by primary oncologist

Where it's running

  • Childrens Hospital Colorado
    Aurora, Colorado, United States
    Recruiting
  • University of Colorado Hospital
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.